User profiles for Frank W. Sellke

Frank Sellke

brown medical school
Verified email at brown.edu
Cited by 123617

2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on …

…, TS Metkus Jr, LC Nnacheta, SV Rao, FW Sellke… - Journal of the American …, 2022 - jacc.org
Aim The guideline for coronary artery revascularization replaces the 2011 coronary artery
bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines, …

[HTML][HTML] Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

…, TA Libermann, JP Morgan, FW Sellke… - The Journal of …, 2003 - Am Soc Clin Investig
Preeclampsia, a syndrome affecting 5% of pregnancies, causes substantial maternal and fetal
morbidity and mortality. The pathophysiology of preeclampsia remains largely unknown. It …

Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke …

…, R Lindquist, PM Nilsson, GC Roman, FW Sellke… - stroke, 2011 - Am Heart Assoc
Background and Purpose— This scientific statement provides an overview of the evidence
on vascular contributions to cognitive impairment and dementia. Vascular contributions to …

Soluble endoglin contributes to the pathogenesis of preeclampsia

…, D Roberts, PA D'Amore, FH Epstein, FW Sellke… - Nature medicine, 2006 - nature.com
Preeclampsia is a pregnancy-specific hypertensive syndrome that causes substantial maternal
and fetal morbidity and mortality. Maternal endothelial dysfunction mediated by excess …

2021 ACC/AHA/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology/American Heart Association …

…, TS Metkus Jr, LC Nnacheta, SV Rao, FW Sellke… - Circulation, 2022 - Am Heart Assoc
Aim: The executive summary of the American College of Cardiology/American Heart
Association/Society for Cardiovascular Angiography and Interventions coronary artery …

[HTML][HTML] Idarucizumab for dabigatran reversal

…, J Kreuzer, JH Levy, FW Sellke… - … England Journal of …, 2015 - Mass Medical Soc
Background Specific reversal agents for non–vitamin K antagonist oral anticoagulants are
lacking. Idarucizumab, an antibody fragment, was developed to reverse the anticoagulant …

Post–cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication a consensus statement from the International liaison Committee on …

…, EP Rivers, A Rodriguez-Nunez, FW Sellke… - Circulation, 2008 - Am Heart Assoc
The contributors to this statement were selected to ensure expertise in all the disciplines
relevant to post–cardiac arrest care. In an attempt to make this document universally applicable …

Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication: a scientific statement from the International liaison Committee on …

…, EP Rivers, A Rodriguez-Nunez, FW Sellke… - Resuscitation, 2008 - Elsevier
AIM OF THE REVIEW: To review the epidemiology, pathophysiology, treatment and
prognostication in relation to the post-cardiac arrest syndrome. METHODS: Relevant articles were …

[HTML][HTML] Idarucizumab for dabigatran reversal—full cohort analysis

…, J Kreuzer, JH Levy, G Royle, FW Sellke… - … England Journal of …, 2017 - Mass Medical Soc
Background Idarucizumab, a monoclonal antibody fragment, was developed to reverse the
anticoagulant effect of dabigatran. Methods We performed a multicenter, prospective, open-…

Management of patients with peripheral artery disease (compilation of 2005 and 2011 accf/aha guideline recommendations) a report of the american college of …

…, RJ Kovacs, EM Ohman, SJ Pressler, FW Sellke… - Circulation, 2013 - Am Heart Assoc
This document is a compilation of the current American College of Cardiology Foundation/American
Heart Association (ACCF/AHA) practice guideline recommendations for peripheral …